申请人:Astellas Pharma Inc.
公开号:EP2963036A1
公开(公告)日:2016-01-06
[Problem]
A compound which is useful as an active ingredient of a pharmaceutical composition for treating storage dysfunctions, voiding dysfunctions, and lower urinary tract diseases is provided.
[Means for Solution]
The present inventors have found that a thiazole derivative having pyrazine-2-carbonylamino substituted at the 2-position is an excellent muscarinic M3 receptor positive allosteric modulator, and is useful as an agent for preventing and/or treating bladder or urinary tract diseases, related to bladder contraction by a muscarinic M3 receptor, thereby completing the present invention. The 2-acylaminothiazole derivative or a salt thereof of the present invention can be used as an agent for preventing and/or treating bladder or urinary tract diseases, related to bladder contraction by a muscarinic M3 receptor, for example, voiding dysfunctions such as underactive bladder.
问题
本发明提供了一种化合物,该化合物可作为药物组合物的活性成分,用于治疗储尿功能障碍、排尿功能障碍和下尿路疾病。
[解决方法]
本发明人发现,在 2-位上具有吡嗪-2-羰基氨基取代的噻唑衍生物是一种优良的毒蕈碱 M3 受体正异位调节剂,可用作预防和/或治疗与毒蕈碱 M3 受体引起的膀胱收缩有关的膀胱或尿路疾病的药物,从而完成了本发明。本发明的 2-酰氨基噻唑衍生物或其盐可用作预防和/或治疗与毒蕈碱类 M3 受体的膀胱收缩有关的膀胱或尿路疾病的药物,例如,排尿功能障碍,如膀胱功能不足。